Yoon Hong Choi

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. ncbi Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales
    Yoon Hong Choi
    Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
    PLoS ONE 7:e39927. 2012
  2. ncbi Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model
    Yoon Hong Choi
    Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
    Vaccine 30:3383-8. 2012
  3. ncbi Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
    Alessia Melegaro
    DONDENA Centre for Research on Social Dynamics, Bocconi University, Via Guglielmo Rontgen, Milan, Italy
    BMC Infect Dis 10:90. 2010
  4. ncbi The potential for measles transmission in England
    Yoon Hong Choi
    Centre for Infections, Health Protection Agency, Colindale, NW9 5EQ, London
    BMC Public Health 8:338. 2008
  5. ncbi Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
    Yoon Hong Choi
    Immunisation Department, HPA Centre for Infections, 61 Colindale Avenue, Colindale, London, United Kingdom
    Vaccine 28:4091-102. 2010
  6. ncbi 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
    Yoon Hong Choi
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 6:e26190. 2011
  7. ncbi Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
    Mark Jit
    Health Protection Agency, London NW9 6BT, UK
    BMJ 343:d5775. 2011
  8. ncbi The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Services, Colindale, Health Protection Agency, London NW9 5EQ, UK
    Vaccine 30:7205-13. 2012
  9. ncbi Economic evaluation of human papillomavirus vaccination in the United Kingdom
    Mark Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London NW9 6BT
    BMJ 337:a769. 2008

Detail Information

Publications9

  1. ncbi Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales
    Yoon Hong Choi
    Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
    PLoS ONE 7:e39927. 2012
    ....
  2. ncbi Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model
    Yoon Hong Choi
    Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
    Vaccine 30:3383-8. 2012
    ..Misattribution of the causal HPV type for a particular abnormality may give rise to an apparent increase in disease due to non-vaccine HPV types following vaccination ("unmasking")...
  3. ncbi Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
    Alessia Melegaro
    DONDENA Centre for Research on Social Dynamics, Bocconi University, Via Guglielmo Rontgen, Milan, Italy
    BMC Infect Dis 10:90. 2010
    ..However the long term effects of PCV are still unclear, as beneficial direct and herd immunity effects might be countered by serotype replacement...
  4. ncbi The potential for measles transmission in England
    Yoon Hong Choi
    Centre for Infections, Health Protection Agency, Colindale, NW9 5EQ, London
    BMC Public Health 8:338. 2008
    ..Maintaining elimination requires low susceptibility levels to keep the effective reproduction number R below 1. Since 1995, however, MMR coverage in two year old children has decreased by more than 10%...
  5. ncbi Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
    Yoon Hong Choi
    Immunisation Department, HPA Centre for Infections, 61 Colindale Avenue, Colindale, London, United Kingdom
    Vaccine 28:4091-102. 2010
    ..The marginal benefit of vaccinating boys depends on the degree of protection achieved by vaccinating girls...
  6. ncbi 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
    Yoon Hong Choi
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    PLoS ONE 6:e26190. 2011
    ..However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US...
  7. ncbi Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
    Mark Jit
    Health Protection Agency, London NW9 6BT, UK
    BMJ 343:d5775. 2011
    ....
  8. ncbi The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Services, Colindale, Health Protection Agency, London NW9 5EQ, UK
    Vaccine 30:7205-13. 2012
    ....
  9. ncbi Economic evaluation of human papillomavirus vaccination in the United Kingdom
    Mark Jit
    Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London NW9 6BT
    BMJ 337:a769. 2008
    ..To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom...